5-128332993-G-T

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 3P and 13B. PM1PP2BP4_StrongBP6BS1BS2

The NM_001999.4(FBN2):​c.4141C>A​(p.His1381Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00512 in 1,608,724 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 23 hom. )

Consequence

FBN2
NM_001999.4 missense

Scores

1
9
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:15

Conservation

PhyloP100: 5.62
Variant links:
Genes affected
FBN2 (HGNC:3604): (fibrillin 2) The protein encoded by this gene is a component of connective tissue microfibrils and may be involved in elastic fiber assembly. Mutations in this gene cause congenital contractural arachnodactyly. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PM1
In a domain EGF-like 22; calcium-binding (size 40) in uniprot entity FBN2_HUMAN there are 7 pathogenic changes around while only 2 benign (78%) in NM_001999.4
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FBN2. . Gene score misZ 1.5491 (greater than the threshold 3.09). Trascript score misZ 3.2752 (greater than threshold 3.09). GenCC has associacion of gene with familial thoracic aortic aneurysm and aortic dissection, carpal tunnel syndrome, macular degeneration, early-onset, congenital contractural arachnodactyly.
BP4
Computational evidence support a benign effect (MetaRNN=0.012713194).
BP6
Variant 5-128332993-G-T is Benign according to our data. Variant chr5-128332993-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 210996.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=7, Uncertain_significance=1}. Variant chr5-128332993-G-T is described in Lovd as [Likely_benign]. Variant chr5-128332993-G-T is described in Lovd as [Benign]. Variant chr5-128332993-G-T is described in Lovd as [Likely_pathogenic].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00323 (492/152278) while in subpopulation NFE AF= 0.00529 (360/68032). AF 95% confidence interval is 0.00484. There are 1 homozygotes in gnomad4. There are 238 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 492 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBN2NM_001999.4 linkuse as main transcriptc.4141C>A p.His1381Asn missense_variant 32/65 ENST00000262464.9 NP_001990.2
FBN2XM_017009228.3 linkuse as main transcriptc.3988C>A p.His1330Asn missense_variant 31/64 XP_016864717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBN2ENST00000262464.9 linkuse as main transcriptc.4141C>A p.His1381Asn missense_variant 32/651 NM_001999.4 ENSP00000262464 P1P35556-1

Frequencies

GnomAD3 genomes
AF:
0.00323
AC:
492
AN:
152160
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00606
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00529
Gnomad OTH
AF:
0.00336
GnomAD3 exomes
AF:
0.00372
AC:
934
AN:
251292
Hom.:
2
AF XY:
0.00360
AC XY:
489
AN XY:
135818
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00133
Gnomad ASJ exome
AF:
0.00675
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00154
Gnomad FIN exome
AF:
0.00402
Gnomad NFE exome
AF:
0.00576
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00531
AC:
7739
AN:
1456446
Hom.:
23
Cov.:
29
AF XY:
0.00511
AC XY:
3702
AN XY:
724838
show subpopulations
Gnomad4 AFR exome
AF:
0.000689
Gnomad4 AMR exome
AF:
0.00177
Gnomad4 ASJ exome
AF:
0.00656
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00169
Gnomad4 FIN exome
AF:
0.00386
Gnomad4 NFE exome
AF:
0.00622
Gnomad4 OTH exome
AF:
0.00352
GnomAD4 genome
AF:
0.00323
AC:
492
AN:
152278
Hom.:
1
Cov.:
32
AF XY:
0.00320
AC XY:
238
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00101
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00606
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00187
Gnomad4 FIN
AF:
0.00264
Gnomad4 NFE
AF:
0.00529
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00535
Hom.:
9
Bravo
AF:
0.00305
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00558
AC:
48
ExAC
AF:
0.00368
AC:
447
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00371
EpiControl
AF:
0.00456

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:15
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxJun 22, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 22, 2017- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 21, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMay 09, 2014- -
not provided Benign:4
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024FBN2: BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 14, 2023- -
Congenital contractural arachnodactyly Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Connective tissue disorder Benign:2
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenFeb 01, 2020- -
Likely benign, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncNov 01, 2016- -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 05, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenApr 29, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.080
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.68
D;.;D;D;D
Eigen
Benign
0.054
Eigen_PC
Uncertain
0.22
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.86
D;.;.;D;D
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.013
T;T;T;T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
-1.5
N;.;N;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-4.3
D;.;D;D;D
REVEL
Uncertain
0.55
Sift
Benign
0.29
T;.;T;T;T
Sift4G
Benign
1.0
.;.;.;T;T
Polyphen
0.82
P;.;P;.;P
Vest4
0.43
MVP
0.45
MPC
0.89
ClinPred
0.036
T
GERP RS
4.9
Varity_R
0.29
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78727187; hg19: chr5-127668685; COSMIC: COSV99075149; API